Publications by authors named "John Barbieri"

Claim this Profile
T
The effect of isotretinoin treatment for acne vulgaris on height in adolescents: A retrospective cohort study using the Rochester Epidemiology Project.
Kathryn K Xu, Nessa Aghazadeh, Peter Tebben, Austin Todd, Megha Tollefson, John S Barbieri

J Am Acad Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validating the Use of ICD-10 Codes for Identifying Vitiligo.
Debby Cheng, Katherine Sanchez, Ursula Biba, Nora Bensellam, Sherry Ershadi, John S Barbieri

JAMA Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Report From the 2024 International Dermatology Outcome Measures (IDEOM) Annual Meeting.
Sarah Romanelli, Gretchen D Ball, Arianna J Zhang, Christina Asare, Audrey Hao, John S Barbieri

J Drugs Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rates of missed windows and premature treatment discontinuation for those treated with isotretinoin via telemedicine.
Sherry Ershadi, John S Barbieri

J Am Acad Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical medications for moderate-to-severe rosacea: protocol for a living systematic review and network meta-analysis.
Anissa Valentina Amstutz, Anne Fladger, Abizairie Sanchez-Feliciano, John S Barbieri

BMJ Open· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurement Properties of PROMIS Measures Relevant to Chronic Skin Diseases.
Michael R Nock, Sherry Ershadi, Abizairie Sánchez-Feliciano, Anissa Valentina Amstutz, David J Margolis, John S Barbieri

JAMA Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucagon-like peptide-1 receptor agonists in the adjunctive treatment of patients with hidradenitis suppurativa: A systematic review.
Abizairie Sánchez-Feliciano, Henry Herrera, Alexandra Charrow, John S Barbieri

J Am Acad Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Serious Infection With Adalimumab in Hidradenitis Suppurativa Compared With Psoriasis.
Bruna Galvao de Oliveira Wafae, Alexandra P Charrow, David Stein, John S Barbieri, Megan H Noe

JAMA Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prices and Spending for Phosphodiesterase 4 Inhibitors in Pulmonary and Dermatologic Disease.
Nikhita J Perry, John S Barbieri, Benjamin N Rome

JAMA Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prior authorization denials lack transparency and accountability.
Sherry Ershadi, Ana B W Greenberg, Samara Katini, John S Barbieri, Jeffrey M Cohen

J Am Acad Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Periorificial dermatitis: Pathophysiology, diagnosis, and management.
Lorena A Acevedo-Fontanez, Abizairie Sánchez-Feliciano, Sherry Ershadi, Jason Reichenberg, Lawrence F Eichenfield, John S Barbieri

J Am Acad Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial Intelligence Use in Acne Diagnosis and Management-A Scoping Review.
Katie L Frederickson, Haiwen Gui, John S Barbieri, Roxana Daneshjou

Int J Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Public perceptions on the medical versus cosmetic nature of dermatologic conditions.
Aliya Shabbir, Avery H LaChance, John S Barbieri

J Am Acad Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing Formulary Accessibility: a Step Toward Better Care.
Victor C Agbafe, Aaron S Kesselheim, John S Barbieri

J Gen Intern Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric isotretinoin use for acne is not associated with meaningful effects on adult height: A retrospective cohort study using TriNetX.
Hannah L Cole, John S Barbieri, Lisa Y Shen

J Am Acad Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of major systemic complications in patients with cutaneous vasculitis: A retrospective cohort study.
Arjun Mahajan, John Barbieri, Evan W Piette

JAAD Int· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the atopic dermatitis control tool in pediatric patients with atopic dermatitis.
Sarah Lee, Jennifer LeBovidge, Laura Berbert, John S Barbieri, Lynda Schneider

J Am Acad Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and prevalence of perioral dermatitis in the United States: A retrospective cohort study using TriNetX.
Christopher J Thang, David Garate, Jenny Lai, Sherry Ershadi, George Golovko, John S Barbieri

J Am Acad Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Trial of Coach-Supported, Smartphone-Delivered Cognitive Behavioral Therapy for Psoriasis With Comorbid Depression.
John S Barbieri, Megan H Noe, Nora Bensellam, Phoebe Holz, Bruna G O Wafae

J Psoriasis Psoriatic Arthritis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Veenstra et al's "Benzoyl peroxide acne treatment shows no significant association with benzene-related cancers: A multicenter retrospective analysis" on statistical design.
Christopher G Bunick, Kerry Yang, Fatemeh Jafarian, John S Barbieri

J Am Acad Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric JAK Inhibitor Use and Height in Common Inflammatory Diseases.
Hannah L Cole, Lisa Y Shen, John S Barbieri

JAMA Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mosaic Ring 20 Syndrome: A Meta-Analysis.
Sarah Woodson, William D James, Rudolf Roth, John S Barbieri, Sherry Ershadi

Neurol Genet· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Access Deferred Is Access Denied: Small Molecule Drug Pricing and the Future of Dermatology.
Nikhita J Perry, John S Barbieri, Lee A Fleisher

Int J Dermatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spironolactone for Acne: Practical Strategies for Optimal Clinical Outcomes.
Sherry Ershadi, John S Barbieri

Cutis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity in Specifications of At-Home Red and Blue LED Masks for Acne Treatment in the U.S. Market.
Sherry Ershadi, Nikki Zangenah, Chavely Calderon, Nora Bensellam, Arash Mostaghimi, John S Barbieri

Int J Dermatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis